Bexitrol F contains two active components: Salmeterol Xinafoate and Fluticasone Propionate, each serving a unique purpose in managing asthma and related airway conditions:
Salmeterol Xinafoate:
Fluticasone Propionate:
This combination ensures both symptom relief (via Salmeterol) and long-term management of airway inflammation (via Fluticasone), offering a convenient therapeutic option for patients requiring both treatments concurrently.

⚠️Disclaimer:
At ePharma, we’re committed to providing accurate and accessible health information. However, all content is intended for informational purposes only and should not replace medical advice from a qualified physician. Please consult your healthcare provider for personalized guidance. We aim to support, not substitute, the doctor-patient relationship.